Assessment of genetic markers for coronary thrombosis: promise and precaution
- 1 February 1999
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 353 (9154) , 687-688
- https://doi.org/10.1016/s0140-6736(99)00067-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. menJournal of the American College of Cardiology, 1998
- The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary AtherosclerosisNew England Journal of Medicine, 1998
- Factor V Leiden Mutation and the Risks for Thromboembolic Disease: A Clinical PerspectiveAnnals of Internal Medicine, 1997
- PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosisThe Lancet, 1997
- A Polymorphism of a Platelet Glycoprotein Receptor as an Inherited Risk Factor for Coronary ThrombosisNew England Journal of Medicine, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- A Prospective Evaluation of an Angiotensin-Converting–Enzyme Gene Polymorphism and the Risk of Ischemic Heart DiseaseNew England Journal of Medicine, 1995
- Myocardial infarction associated with homozygous resistance to activated protein CThe Lancet, 1994
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992